Atomized Intranasal Ketorolac Versus Intravenous Ketorolac for the Treatment of Severe Renal Colic in the Emergency Department: A Double-Blind, Randomized Controlled Trial

• Published in: Annals of emergency medicine 2024-03, Vol.83 (3), p.217-224
• Main Authors: Al-Khalasi, Usama Said Shannan, Al-Sarrai Al-Alalawi, Awatif Khamis Said, Al-Jufaili, Mahmood, Al-Reesi, Abdullah, Al-Zakwani, Ibrahim, Al-Asmi, Muzna Said Rashid, Al-Riyami, Fatma Bader, Vishwakarma, Ramesh
• Format: Article
• Language: English
• Subjects: Administration, Intravenous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Colic - drug therapy; Double-Blind Method; Emergency Service, Hospital; Humans; Ketorolac - therapeutic use; Middle Aged; Pain - drug therapy; Renal Colic - drug therapy; Young Adult
• ISSN: 0196-0644; 1097-6760
• DOI: 10.1016/j.annemergmed.2023.10.009

Atomized intranasal (IN) drug administration offers an alternative to the intravenous (IV) route. We aimed to evaluate the analgesic efficacy of IN versus IV ketorolac in emergency department patients with acute renal colic. We conducted a double-blind, randomized controlled trial on adult patients (aged 18 to 64 years) with severe renal colic and numerical rating scale pain ratings ≥7.0. They were randomly assigned (1:1) to receive single doses of either IN or IV ketorolac. Our main outcomes were differences in numerical rating scale reduction at 30 and 60 minutes. A 95% confidence interval (CI) was calculated for each mean difference, with a minimum clinically important difference set at 1.3 points. Secondary outcomes included treatment response, adverse events, rescue medications, and emergency department revisits. We analyzed using intention-to-treat. A total of 86 and 85 patients with similar baseline characteristics were allocated to the IV and IN groups, respectively. Mean numerical rating scale scores were 8.52 and 8.65 at baseline, 3.85 and 4.67 at 30 minutes, and 2.80 and 3.04 at 90 minutes, respectively. The mean numerical rating scale reduction differences between the IV and IN groups were 0.69 (95% CI -0.08 to 1.48) at 30 minutes and 0.10 (95% CI -0.85 to 1.04) at 60 minutes. There were no differences in secondary outcomes. Neither IN or IV ketorolac was superior to the other for the treatment of acute renal colic, and both provided clinically meaningful reductions in pain scores at 30 to 60 minutes.